# Roflumilast in Non-CF Bronchiectasis Study (2019)

> **NCT04322929** · PHASE2 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 42 (actual)

## Conditions studied

- Non-cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** Roflumilast Oral Tablet

## Key facts

- **NCT ID:** NCT04322929
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-12
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322929, "Roflumilast in Non-CF Bronchiectasis Study (2019)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04322929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*